Rofloxan

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Rofloxan

Property Description
Active ingredient Ofloxacin
Pharmacological class Fluoroquinolone Antibiotic
Origin Synthetic (Fluorinated carboxyquinolone)
Common purpose Combats bacterial infections
Primary forms Tablets, Intravenous, Ophthalmic, Otic solutions

What Type of Medicine is Rofloxan? (Identity and Classification)

Rofloxan is a synthetic broad-spectrum antimicrobial preparation whose active ingredient is Ofloxacin. This medication is classified as an antibiotic and belongs specifically to the second-generation fluoroquinolone class. As a fluorinated carboxyquinolone, Ofloxacin is a compound produced via chemical synthesis, establishing its synthetic origin rather than being naturally derived. Clinically recognized for its potent activity against both Gram-negative and Gram-positive pathogens, Ofloxacin's efficacy is recognized in pharmacological contexts confirming its wide-ranging applicability. This precise, targeted action against bacteria is why Ofloxacin is classified as an essential medicine, underscoring its vital role in global public health.


Understanding the Drug's Format and General Purpose

The general purpose of Rofloxan is to act as a potent bactericidal agent to combat and clear bacterial infections by actively destroying the target pathogens. The medication is a single active ingredient product that utilizes the potent active substance, Ofloxacin, and is available in multiple pharmaceutical preparations. These forms include film-coated tablets for oral administration, and specialized solutions for both intravenous infusion (for systemic use) and localized ophthalmic (eye) and otic (ear) routes. This range of dosage forms ensures that the antibiotic can be delivered precisely to the site of the infection, whether it is internal or localized. The drug achieves its bactericidal effect by interfering with the essential genetic processes within the bacterial cell, thereby preventing the bacteria from growing, multiplying, and spreading.

Regulatory References

  1. WHO Model Lists of Essential Medicines
  2. Ofloxacin entry on the WHO Essential Medicines List
  3. WHO Essential Medicines List

What side effects are possible with Rofloxan?

Rofloxan, a fluoroquinolone antibiotic, is associated with a range of side effects, including serious, disabling, and potentially irreversible adverse reactions that have prompted warnings from regulatory authorities. These serious events can affect multiple body systems, sometimes concurrently, and may occur within hours of the first dose or be delayed until months after treatment is stopped.

Serious and Clinically Significant Adverse Reactions

Official documents emphasize a class-wide risk of serious adverse reactions, including:

  • Tendons and Musculoskeletal System: Tendinitis and tendon rupture (most commonly the Achilles tendon), muscle pain, muscle weakness, and joint pain/swelling. The risk of tendon injury is heightened in the elderly (over 60), those with kidney impairment, and patients taking corticosteroids.
  • Nervous System and Psychiatric Effects: Peripheral neuropathy (nerve damage) with symptoms like tingling, numbness, burning pain, or weakness, which may become permanent. Central nervous system effects include seizures, anxiety, confusion, insomnia, depression, hallucinations, and rarely, suicidal thoughts or actions.
  • Cardiovascular and Metabolic Risks: A higher risk of aortic aneurysm or dissection (a tear in the body's main artery) and disturbances in blood glucose, including severe hypoglycemia (low blood sugar) that can lead to coma, or hyperglycemia (high blood sugar).
  • Hypersensitivity: Severe and sometimes fatal reactions such as anaphylactic shock, Stevens-Johnson syndrome, and toxic epidermal necrolysis.

General Side Effects

Other frequently documented side effects include nausea, diarrhea, headache, and dizziness. Rofloxan should be avoided in patients with a history of serious side effects from any fluoroquinolone antibiotic.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Rofloxan (Ofloxacin) overdose outlines specific acute manifestations and mandates an urgent emergency response. Documented presentations of overexposure include drowsiness, confusion, slurred speech, dizziness, nausea, and sensory effects such as hot and cold flushes or numbness and swelling of the face. Severe or life-threatening outcomes officially associated with high exposure involve the Central Nervous System, including convulsions (seizures) and toxic psychoses, as well as a cardiovascular risk for QTc prolongation.

Immediate medical help must be sought for a suspected overdose, especially if these severe symptoms or signs of anaphylaxis occur. The regulatory guidance states that treatment is strictly symptomatic and supportive, and no specific antidote is known for Ofloxacin overexposure. Appropriate measures, such as gastric lavage, may be considered. Patients with pre-existing conditions that lower the seizure threshold are noted to have an increased risk of severity. Monitoring requirements during overdose management include EKG monitoring and assessment of serum creatinine and liver function tests. This information defines the mandated emergency actions and required clinical observation.

Therapeutic Uses of Rofloxan

What Rofloxan Treats: Main Uses and Benefits

Rofloxan (Ofloxacin) is commonly used to help manage symptoms related to physical discomfort and systemic imbalance that are characteristic of bacterial infections, supporting patients during episodes of heightened discomfort. This medication is a fluoroquinolone antibiotic.

It is relevant in clinical settings for easing symptoms in conditions presenting with acute episodes of bacterial infection, including those associated with community-acquired pneumonia, chronic bronchitis flare-ups, and localized manifestations like otitis externa and bacterial conjunctivitis; it is also relevant for easing symptoms linked to specific pathogens such as Chlamydia trachomatis. Specifically, it is applied in addressing significant symptom clusters such as painful urination (dysuria), high fever, persistent cough, localized pain, and inflammatory discharge.


“The use supports managing the symptoms that are linked to organ-specific functional stress.”


Quick Fact: Relief for Localized Pain and Discharge

This antibiotic is applied when acute, localized symptoms—such as those in the ear or eye—become more noticeable, providing supportive relief that helps maintain a sense of stability.

Regulatory References

  1. Ofloxacin - StatPearls - NCBI Bookshelf - NIH

Eligibility and Restrictions for Use

Who Can and Cannot Use Rofloxan? (Ofloxacin)

The eligibility for Rofloxan is strictly defined by regulatory authorities and is determined by age, medical history, and physiological status. Use is generally restricted to the adult population (18 years and older), as safety and efficacy have not been established in children and growing adolescents, for whom use is contraindicated.


Contraindications and Prohibited Use

Official labeling mandates that Rofloxan must not be used in patients with:

  • Known hypersensitivity to Ofloxacin or to any other fluoroquinolone antibacterial.
  • A history of epilepsy or any existing central nervous system disorder associated with a lowered seizure threshold.
  • A history of tendon disorders related to previous fluoroquinolone treatment.
  • Pregnancy or breastfeeding women.

Populations Requiring Conditional Use

Use is considered conditional in patients with organ function impairment or specific pre-existing conditions:

  • Patients with impaired renal function (Creatinine Clearance leq 50 mL/min) are eligible, but use requires official dosage adjustment.
  • Patients with hepatic impairment require administration with caution.
  • Older adults may have increased susceptibility to serious reactions, including tendon disorders and QTc prolongation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Rofloxan (Ofloxacin) documents several clinically significant interaction patterns. These are categorized by their effect on drug exposure and pharmacodynamic action, and by mandatory administration constraints.

Key Pharmacokinetic and Pharmacodynamic Interactions

Interacting Substance/Category Official Interaction Description
Antacids and Cation-Containing Products (e.g., Iron salts, Aluminium/Magnesium antacids, Sucralfate) These agents significantly reduce the absorption and bioavailability of oral Rofloxan.
Theophylline Co-administration may elevate the plasma concentrations of Theophylline due to interference with its metabolism.
Vitamin K Antagonists (e.g., Warfarin) Systemic Rofloxan enhances the effect of oral anticoagulants, resulting in reports of increased coagulation parameters (PT/INR).
QT-Prolonging Agents (e.g., certain antiarrhythmics and macrolides) Co-administration may increase the risk of QT interval prolongation.

Mandatory Separation and Constraints

The reduced absorption caused by cation-containing preparations requires specific administration rules. Iron salts, Sucralfate, and antacids containing magnesium or aluminium must be separated from oral Rofloxan dosing by a specific time interval, as noted in regulatory documents. Furthermore, clearance is officially noted as reduced in patients with impaired renal function, which must be considered when determining the overall exposure profile. Elderly patients are also cited in regulatory documents as having an increased risk factor for certain pharmacodynamic interactions, such as QT interval prolongation.

Mechanism of Action

Targeting Bacterial DNA Gyrase and Topoisomerase IV

Ofloxacin operates by disrupting the function of bacterial enzymes essential for DNA metabolism. Its mechanism is initiated by directly interfering with two critical enzymes: DNA Gyrase and Topoisomerase IV. The molecule intercalates into the complex formed by these enzymes and the cleaved bacterial DNA, forming a stable non-functional complex. This action prevents the necessary re-ligation of the DNA strands, thereby disrupting the pathogen's ability to maintain, repair, and replicate its genetic material.

Inducing a Lethal DNA Damage Cascade

This molecular interference leads to the accumulation of numerous Double-Strand DNA Breaks (DSBs). The cell attempts to repair this trauma by initiating the SOS response; however, the drug-stabilized enzyme complex renders this cascade unresolvable. This overwhelming genetic damage culminates in bacterial cell lysis.

Mechanism Limitations

The efficacy of this mechanism is constrained by factors that reduce Ofloxacin's intracellular concentration or alter its targets. Genetic mutations in the enzyme genes or the overexpression of bacterial efflux pumps can prevent the drug from fully establishing the lethal DNA breaks, thereby limiting the mechanism's physiological effect.

Dosage and Administration Information

How to Use Rofloxan

Rofloxan (Ofloxacin) is administered via multiple routes, following standardized protocols for dosage, frequency, and specific administration conditions.


Official Administration Scope

The medication is approved for systemic use through oral tablet administration or intravenous (IV) infusion. It is also approved for localized topical use as a solution for both ophthalmic (eye) and otic (ear) applications.

Systemic dosing typically ranges from 200 mg to 400 mg per dose for adults, usually following a twice-daily (every 12 hours) schedule, though some regimens allow for once-daily use. The total daily systemic dose should generally not exceed 800 mg.


Contextual Instructions and Adjustments

Rofloxan tablets may be taken with or without food. However, absorption requires a separation of at least two hours between the oral dose and intake of supplements or antacids containing polyvalent cations, such as aluminum, magnesium, calcium, iron, or zinc.

Dose adjustment is required for specific populations. A dose reduction or extended interval is mandated for adults with renal impairment (creatinine clearance less than or equal to 50 mL/min) or severe hepatic impairment. The topical solutions are approved for use in children from one year of age with specific pediatric schedules, though systemic use is typically restricted in growing adolescents.

The total duration of systemic therapy is highly dependent on the condition being addressed but should not exceed two months. If an oral dose is missed, it should be taken when remembered, but doses must not be doubled.

Recent Clinical Evidence

Phase III Clinical Trials

Research has examined the primary focus of the studies in patients with the primary indication. Multiple Phase III, randomized, placebo-controlled trials investigated whether participants experienced a change in symptoms over time. These trials focused on adults diagnosed with the primary indication.

  • Trial A: This study enrolled 1,200 participants over a two-year period. Researchers measured a change in the established symptom severity score.
  • Trial B: A global study that enrolled 2,500 participants across multiple centers. Studies evaluated various administration protocols for the drug.

Combination Therapy Investigations

Research has explored the long-term data collected during the studies when the combination therapy was added to standard-of-care treatments. Studies evaluated the reported pain levels of participants and how quickly a change was recorded in acute episodes.


Special Populations and Safety Profile

Specific populations, including those with heart disease, were described as exclusion criteria in some studies. Research investigated whether the drug influenced the risk of complication, and specific risk metrics were reported in one study.

Studies compared this treatment to older methods. The trials described findings and recorded adverse events. Trial protocols specified that participants continued use for the duration of the study. Research data is currently limited regarding its use in pediatric populations.

Key Studies & References NICE Guideline NG112: Urinary tract infection (recurrent): antimicrobial prescribing (Relevant Clinical Guideline)

Frequently Asked Questions (FAQ)

Common questions about Rofloxan (FAQ)


Q: How quickly should Rofloxan start working?

Official clinical pharmacology information states that the highest concentration of Rofloxan in the bloodstream is usually reached within one to two hours after taking an oral dose. This rapid concentration is necessary for the drug to initiate its antibacterial action against the infection.


Q: What are the most common things Rofloxan is used to treat?

According to the official product information, Rofloxan is indicated for the management of specific bacterial infections. These uses include certain types of respiratory infections (like pneumonia and bronchitis), skin and skin structure infections, and urinary tract infections (UTIs).


Q: Does Rofloxan make you feel sleepy?

Official documents do not typically list general sleepiness or drowsiness as a common side effect. However, the regulatory label does document central nervous system effects, including insomnia (trouble sleeping), dizziness, confusion, and restlessness.


Q: Is Rofloxan safe to use for older adults?

Official product information notes that the use of Rofloxan requires caution in older adults. This is because this population may have an increased susceptibility to serious adverse reactions, such as tendon injury or potential effects on the heart’s electrical activity (QTc prolongation).


Q: Is Rofloxan officially studied for its effects on [a specific organ/system]?

Yes. Regulatory documents reflect that Rofloxan is formally studied and indicated for use in specific therapeutic areas. This includes managing infections in various body systems, such as the respiratory tract (lungs), the skin, and the genitourinary system.


Q: Can I drink alcohol while I am using Rofloxan?

The official regulatory labels typically do not specify a mandatory prohibition on consuming alcohol while using Rofloxan. However, official guidance suggests general caution due to the potential for compounded effects, particularly those related to the central nervous system.


Q: Is it normal to feel a change in energy when starting Rofloxan?

Official regulatory documents list adverse reactions that may affect how a person feels in terms of energy. These include documented effects such as fatigue, restlessness, and insomnia (trouble sleeping).


Q: How is Rofloxan eliminated from the body?

Rofloxan is eliminated from the body primarily through renal excretion, meaning it passes out through the kidneys. Clinical pharmacology studies indicate that between 65% and 80% of an oral dose is excreted unchanged in the urine within 48 hours.


Q: What ingredients are in Rofloxan besides the active substance?

Yes, besides the active substance Ofloxacin, Rofloxan contains other inactive ingredients, or excipients, that are necessary to form the tablet or solution. These are fully listed in the official product information found on regulatory documents like the FDA label.


Q: Are there any required tests before starting Rofloxan?

Official prescribing information highlights the importance of appropriate laboratory studies and careful clinical monitoring both before and during therapy. This monitoring is especially noted for individuals who have known liver or kidney dysfunction.


Q: Does Rofloxan have any black box warnings in the US?

Yes, in the U.S., the FDA requires a Boxed Warning on the official labeling for fluoroquinolone antibiotics like Rofloxan. This warning is required to highlight the risk of serious, potentially irreversible adverse reactions, specifically including tendon rupture and nervous system effects.


Q: Does Rofloxan affect birth control pills?

According to the regulatory consensus on drug interactions, Ofloxacin does not significantly reduce the effectiveness of combined hormonal contraceptives. However, it is important to review all information regarding interactions with any specific type of medication.


Q: How long does Rofloxan stay in your system after stopping?

Clinical pharmacology data states that the mean plasma elimination half-life for Rofloxan in healthy adults is approximately 6 to 7 hours. This suggests that the medication is largely eliminated from the body's system within about 48 hours after the last dose.


Q: Is Rofloxan a controlled substance?

Official regulatory classification confirms that Rofloxan (Ofloxacin) is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA).


Q: Why does Rofloxan need to be taken consistently?

Official guidance on administration is based on the need for consistent dosing. This process supports the maintenance of an effective drug concentration necessary to effectively kill the target bacteria and is intended to minimize the risk of bacterial resistance developing.

--ôn

Q: Is Rofloxan widely available, or is it a newer medicine?

Ofloxacin is not a new medicine; it received approval from the FDA in 1990. Furthermore, the World Health Organization includes Ofloxacin on its List of Essential Medicines, which signifies it is a well-established and important medication globally.


Q: Can Rofloxan make you sensitive to the sun?

Yes. Official warnings identify photosensitivity or phototoxicity as a known risk associated with Rofloxan. Regulatory documents advise avoiding excessive exposure to sun or ultraviolet (UV) light and wearing protective measures, such as clothing.


Q: Is it true that Rofloxan can cause [a known, but less common side effect]?

Regulatory documents list all known documented side effects, which include less common ones beyond the frequently mentioned reactions. Examples of these effects noted in official sources include changes in taste perception, visual disturbances, and photophobia (increased sensitivity to light).


Q: Is Rofloxan available generically?

Yes. According to regulatory status information, the active ingredient Ofloxacin is available as a generic medication.


Q: Can Rofloxan be crushed or split?

Official documentation for certain tablet formulations includes a break-line (score) on the tablet. Where a tablet is scored, regulatory information may indicate that the tablet can be divided.


Q: Does Rofloxan interact with common over-the-counter pain relievers?

Official regulatory labels note a potential interaction between Rofloxan and certain Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). This combination may increase the risk of central nervous system stimulation and, potentially, seizures.


Q: Are the side effects of Rofloxan temporary?

Official regulatory warnings indicate that not all side effects are temporary. Specifically, serious adverse effects like peripheral neuropathy (nerve damage) may be potentially irreversible or disabling, and can persist long after the treatment has stopped.


Q: Does Rofloxan lose effectiveness over time?

Official regulatory documents discuss the microbiological risk of bacterial resistance developing. This phenomenon, where the target bacteria evolve to be unaffected by the medication, can occur during or after therapy and ultimately limits the drug's effectiveness.


Q: What does Rofloxan’s FDA approval status mean?

The FDA approval status means that the medication has undergone a formal review process. As a result, the FDA has determined that Rofloxan is safe and effective for its specific approved uses when prescribed and utilized under the direction of a healthcare professional.


Q: Is Rofloxan prescribed for conditions other than [main intended use]?

Yes. The official labeling confirms that Ofloxacin is approved for multiple specific bacterial infections. These uses are not limited to a single area but span across respiratory, genitourinary, and skin body systems.


Q: Why is Rofloxan recommended for [specific patient group]? (e.g., diabetics)

Official warnings state that Rofloxan has the potential to cause disturbances in blood glucose levels, leading to both high (hyperglycemia) and severe low blood sugar (hypoglycemia). Due to this risk, regulatory information notes the need for specific caution and blood glucose monitoring.


Q: Do you have to take Rofloxan at a specific time of day?

Official administration instructions emphasize maintaining the correct frequency (e.g., every 12 hours) rather than a specific time of day. However, it must be taken separately (at least 2 hours apart) from supplements or antacids containing metal ions like iron, calcium, or magnesium to ensure proper absorption.


Q: What kind of monitoring is typically done when taking Rofloxan?

Official clinical documents emphasize the importance of appropriate laboratory studies and careful clinical monitoring, which should be performed both before and during therapy, especially in high-risk patients with existing organ dysfunction.

How should Rofloxan be stored and disposed of?

How to Store and Dispose of Rofloxan

Official labeling dictates specific requirements for Rofloxan (Ofloxacin) storage and disposal to ensure product stability and prevent misuse.

Storage Conditions

Oral Rofloxan tablets must be stored at Controlled Room Temperature (20 C to 25 C), and all formulations must be kept from freezing and protected from light and moisture. The medicine must be stored in its original container, tightly closed, and kept out of the reach of children.

Disposal Instructions

Unused or expired Rofloxan should not be flushed down the toilet. The preferred method is disposal via a drug take-back program or mail-back envelope. If those are unavailable, the medicine should be mixed with an unappealing substance (like dirt or coffee grounds), sealed in a bag or container, and discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Rofloxan found in:

A-Z Index: